Eli Lilly and Company
Isoquinolin and naphthydrin compounds
Last updated:
Abstract:
The present invention provides a compound of Formula II wherein X is selected from the group consisting of CH and N; Q is selected from the group consisting of CH3 and H; R is selected from the group consisting of and; or a pharmaceutically acceptable salt thereof, compositions, methods to treat liver disease and NASH. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
21 Feb 2018
Issue date:
14 Sep 2021